IS SERUM FIBROBLAST GROWTH FACTOR 21 ASSOCIATED WITH THE SEVERITY OR PRESENCE OF CORONARY ARTERY DISEASE?

Creative Commons License

Nar G., Sanlialp S. C., Nar R., Kilic O., Ozen M. F., GÜNVER M. G., ...Daha Fazla

JOURNAL OF MEDICAL BIOCHEMISTRY, cilt.41, sa.2, ss.162-167, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 41 Sayı: 2
  • Basım Tarihi: 2022
  • Doi Numarası: 10.5937/jomb0-30191
  • Dergi Adı: JOURNAL OF MEDICAL BIOCHEMISTRY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, Central & Eastern European Academic Source (CEEAS), EMBASE, Veterinary Science Database, Directory of Open Access Journals
  • Sayfa Sayıları: ss.162-167
  • Anahtar Kelimeler: FGF21, stable angina pectoris, coronary artery disease, ATHEROSCLEROSIS
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background: Recent studies have shown that increased circulating concentrations of fibroblast growth factor 21 (FGF21) are associated with obesity, metabolic disorder, and atherosclerosis. However the relationship between FGF21 and coronary artery disease (CAD) is controversial This study was planned to investigate the role of FGF21 in CAD development and CAD severity.